| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267481.1 |
Docetaxel |
Breast invasive carcinoma |
0.039354246 |
Resistant |
| ENSG00000267481.1 |
Docetaxel |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024375244 |
Resistant |
| ENSG00000267481.1 |
Docetaxel |
Brain lower grade glioma |
0.010977061 |
Resistant |
